Erivedge 150 (Vismodegib Capsule) 150mg

ERIVEDGE 150 (Vismodegib 150mg capsules) is a prescription medication used in cancer care. This 28-capsule pack treats advanced basal cell carcinoma when surgery isn’t suitable. Find ERIVEDGE 150 online for convenient access to targeted therapy.

Strength

150mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Roche

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ERIVEDGE 150 (Vismodegib 150mg) is prescribed to treat adults with metastatic basal cell carcinoma or locally advanced basal cell carcinoma that has recurred after surgery or radiation. It belongs to a class of drugs called hedgehog pathway inhibitors. Patients often ask what ERIVEDGE 150 is used for as part of their cancer treatment plan.

Side Effects

ERIVEDGE 150 (Vismodegib 150mg) capsules work by blocking signals that help cancer cells grow. Many patients notice reduced tumor size over time while taking this medication. Common effects include changes in taste, muscle spasms, or hair loss.

Precautions & Warnings

Keep ERIVEDGE 150 capsules at room temperature away from moisture and heat. Women who are pregnant or may become pregnant should avoid handling this medication due to potential harm to unborn babies. Always follow your healthcare provider’s instructions for safe use.

Avoid Interactions

ERIVEDGE 150 may interact with other medications that affect liver enzymes, such as certain antibiotics or antifungals. Avoid St. John’s wort and grapefruit products while taking this drug. Discuss all current medications with your doctor before starting ERIVEDGE 150.

References

Frequently Asked Questions

ERIVEDGE 150 (Vismodegib 150mg) is used to treat adults with advanced basal cell carcinoma when other treatments are not suitable.

Store ERIVEDGE 150 capsules at room temperature, away from moisture and heat, in their original packaging.

ERIVEDGE 150 may interact with certain drugs; consult your healthcare provider before combining it with other medications.

ERIVEDGE 150 can cause harm to unborn babies; pregnant women or those planning pregnancy should avoid handling this medication.

Common effects may include changes in taste, muscle spasms, or hair loss while taking ERIVEDGE 150.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.